Jianmin Pharmaceutical GroupLtd Dividends and Buybacks
Dividend criteria checks 4/6
Jianmin Pharmaceutical GroupLtd is a dividend paying company with a current yield of 2.84% that is well covered by earnings.
Key information
2.8%
Dividend yield
-0.03%
Buyback Yield
| Total Shareholder Yield | 2.8% |
| Future Dividend Yield | 2.8% |
| Dividend Growth | 9.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥1.200 |
| Payout ratio | 43% |
Recent dividend and buyback updates
No updates
Recent updates
Potential Upside For Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976) Not Without Risk
Nov 10
If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity
Sep 25Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)
Aug 25The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%
Jul 12We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt
Jun 30We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease
May 21We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings
Apr 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 600976's dividend payments have been volatile in the past 10 years.
Growing Dividend: 600976's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Jianmin Pharmaceutical GroupLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (600976) | 2.8% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (600976) (up to 3 years) | 2.8% |
Notable Dividend: 600976's dividend (2.84%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 600976's dividend (2.84%) is in the top 25% of dividend payers in the CN market (2.15%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (43%), 600976's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (201.3%), 600976's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 16:30 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jianmin Pharmaceutical Group Co.,Ltd. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Jing Qiang | China International Capital Corporation Limited |
| Xiaoyu Qian | Huatai United Securities Co., Ltd. |